SavedAdd your journal

Journals / Online Türk Sağlık Bilimleri Dergisi / 2022 / Cilt: 7 - Sayı: 4

Non-Fermenting Gram-Negative Isolates as Infecting Agents and Antibiotic Resistance: Three-Year Data

Enfeksiyon Etkeni Nonfermenter Gram Negatif İzolatlar ve Antibiyotik Dirençleri: Üç Yıllık Veri

Ali Korhan SIĞ
Alev ÇETİN DURAN
Tuğba KULA ATİK
Nermin ÖZEN
Onur IRMAK
Pages
538–545
Publication Date
2022-12-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Objective: This study aimed to investigate clinical non-fermenting gram-negative isolates and antibiotic resistance profiles for three years in a tertiary hospital.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to investigate clinical non-fermenting gram-negative isolates and antibiotic resistance profiles for three years in a tertiary hospital.
📊
Key Findings & Data:Objective: This study aimed to investigate clinical non-fermenting gram-negative isolates and antibiotic resistance profiles for three years in a tertiary hospital.
💡
Conclusion & Impact:Objective: This study aimed to investigate clinical non-fermenting gram-negative isolates and antibiotic resistance profiles for three years in a tertiary hospital.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Acinetobacter · antimicrobial resistance · Burkholderia

Abstract

Objective: This study aimed to investigate clinical non-fermenting gram-negative isolates and antibiotic resistance profiles for three years in a tertiary hospital.

Özet

Amaç: Bu çalışmanın amacı, üç yıllık dönemde bir üçüncü basamak hastanenin enfeksiyon etkeni nonfermenter gram negatif izolatlarını ve antibiyotik direnç profillerini belirlemektir.

🔖

Cite This Article

SIĞ, A. K., DURAN, A. Ç., ATİK, T. K., ÖZEN, N., IRMAK, O. (2022). Non-Fermenting Gram-Negative Isolates as Infecting Agents and Antibiotic Resistance: Three-Year Data. Online Türk Sağlık Bilimleri Dergisi, Cilt: 7 - Sayı: 4, 538–545. https://ajindex.com/articles/862323

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Fuhrmeister AS, Jones RN. The importance of antimicrobial resistance monitoring worldwide and the origins of SENTRY antimicrobial surveillance program. Open Forum Infect Dis. 2019;6(S1):S1–S4. doi:10.1093/ofid/ofy346 National Antimicrobial Surveillance System. https://hsgm.saglik.gov.tr/tr/uamdss. Accessed June 17, 2021. World Health Organization (WHO). Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR), Annual 2020 Report, 2020. https://www.euro.who.int/__data/assets/pdf_file/0003/469200/Central-Asian-and-European-Surveillance-of-Antimicrobial-Resistance.-Annual-report-2020-eng.pdf. Accessed June 17, 2021.
  2. Zhanel GG, Adam HJ, Baxter MR, et al. 42936 pathogens from Canadian hospitals: 10 years of results (2007–16) from the CANWARD surveillance study. J Antimicrob Chemother. 2019;74(Suppl 4):iv5–iv21. doi:10.1093/jac/dkz283 Lagacé-Wiens PR, Adam HJ, et al. Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007–16. J Antimicrob Chemother. 2019;74(Suppl 4):iv22–iv31. doi:10.1093/jac/dkz284 European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual Epidemiological Report 2019. Stockholm: ECDC; 2020. https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2019. Accessed June 17, 2021. Centers for Disease Control and Prevention (CDC). Antibiotic Resistance Threats in the United States, 2019.
  3. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019. doi:10.15620/cdc:82532. Accessed June 17, 2021. WHO priority pathogens list for R&D of new antibiotics. https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed June 17, 2021. Sfeir MM. Burkholderia cepacia complex infections: more complex than the bacterium name suggest. J Infect. 2018;77(3):166-170. doi:10.1016/j.jinf.2018.07.006 Adegoke AA, Stenström TA, Okoh AI. Stenotrophomonas maltophilia as an emerging ubiquitous pathogen: looking beyond contemporary antibiotic therapy. Front Microbiol. 2017;8:2276. doi:10.3389/fmicb.2017.02276 European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0, Basel, Switzerland. https://www.eucast.org. Accessed June 17, 2021. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testin